10 drugmakers work together to write alzheimer history

Alzheimer; News from the web:

Pfizer Inc., Eli Lilly & Co. and eight other large drug makers will partner with the U.S. government in a $230-million effort to identify new approaches to treat Alzheimer’s, diabetes, lupus and arthritis.

Data generated from the work will be made public for other scientists to use, a move the U.S. National Institutes of Health called groundbreaking. The targeted diseases are some of the most prevalent conditions among Americans, costing the nation billions of dollars in treatment and lost productivity.

Read all about it HERE